首页 | 本学科首页   官方微博 | 高级检索  
检索        


Haplotype–Phenotype correlation in Fukuyama congenital muscular dystrophy
Authors:Makiko Osawa  Zhi‐Ping Wang  Kiyoko Ikeya  Yukio Fukuyama  Eri Kondo‐Iida  Tatsushi Toda  Hirofumi Ohashi  Kenji Kurosawa  Shuji Wakai  Ken‐ichiro Kaneko
Institution:1. Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan;2. Laboratory of Genome Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan;3. Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan;4. Department of Pediatrics, Metropolitan Kita Medical and Rehabilitation Center for the Handicapped, Tokyo, Japan;5. Department of Pediatrics, Sapporo Medical University, School of Medicine, Sapporo, Japan;6. Department of Pediatrics, Juntendo University, Urayasu Hospital, Chiba, Japan
Abstract:In typical Fukuyama congenital muscular dystrophy (FCMD), peak motor function is usually only unassisted sitting or sliding on the buttocks, though a few patients are able to walk at some point. However, a few patients have a severe phenotype and never acquire head control. In addition, it is clinically difficult to differentiate this severe FCMD from Walker‐Warburg syndrome (WWS) or from muscle–eye–brain disease (MEBD). In order to establish a genotype–phenotype correlation, we performed haplotype analysis using microsatellite markers closest to the FCMD gene (FCMD) in 56 Japanese FCMD families, including 35 families whose children were diagnosed as FCMD with the typical phenotype, 12 families with a mild phenotype, and 9 families with a severe phenotype. Of the 12 propositi with the mild phenotype, 8 could walk and the other 4 could stand with support; 10 cases were homozygous for the ancestral founder (A‐F) haplotype whereas the other 2 were heterozygous for the haplotype. In the 9 severe cases, who had never acquired head control or the ability to sit without support, 3 had progressive hydrocephalus, 2 required a shunt operation, and 7 had ophthalmological abnormalities. Haplotype analysis showed that 8 of the 9 cases of the severe phenotype are heterozygous for the A‐F haplotype, and the other one homozygous for the haplotype. We confirmed that at least one chromosome in each of the 56 FCMD patients has the A‐F haplotype. The rate of heterozygosity for the A‐F haplotypes was significantly higher in severe cases than in typical or mild cases (P < 0.005). Severe FCMD patients appeared to be compound heterozygotes for the founder mutation and another mutation. Thus, the present study yielded molecular genetic evidence of a broad clinical spectrum in FCMD. Am. J. Med. Genet. 92:184–190, 2000. © 2000 Wiley‐Liss, Inc.
Keywords:genotype–  phenotype correlation  clinical severity  ancestral founder haplotype  compound heterozygosity
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号